Literature DB >> 18061024

HIV-AIDS: urologic considerations.

Steve Lebovitch1, Jack H Mydlo.   

Abstract

The prevalence of HIV continues to grow in the United States and worldwide. HIV-positive patients experience many genitourinary disease processes. With improvements in HIV therapy, patients have questions and concerns pertaining to their quality of life. This article reviews conditions such as HIV-related urinary tract infections, urolithiasis, voiding dysfunction, fertility, sexual dysfunction, HIV-related nephropathy, malignancies, and occupational exposure and prophylaxis. Knowledge of the various HIV manifestations of genitourinary conditions and their treatment options benefits clinicians and improves patient outcomes.

Entities:  

Mesh:

Year:  2008        PMID: 18061024     DOI: 10.1016/j.ucl.2007.09.001

Source DB:  PubMed          Journal:  Urol Clin North Am        ISSN: 0094-0143            Impact factor:   2.241


  6 in total

1.  Aggressive bladder carcinoma in an HIV-positive man with tetraplegia and neurogenic bladder.

Authors:  Justin O Benabdallah; Clinton W Collins; Laura R Carucci; Kenneth E Moores; David R Gater; Adam P Klausner
Journal:  J Spinal Cord Med       Date:  2011       Impact factor: 1.985

Review 2.  HIV-associated bladder cancer: a case series evaluating difficulties in diagnosis and management.

Authors:  Elizabeth M Gaughan; Bruce J Dezube; Mark Bower; David M Aboulafia; Gerry Bohac; Timothy P Cooley; Liron Pantanowitz
Journal:  BMC Urol       Date:  2009-08-31       Impact factor: 2.264

Review 3.  Urologic complications of HIV and AIDS.

Authors:  Chris F Heyns; Adam E Groeneveld; Nelson B Sigarroa
Journal:  Nat Clin Pract Urol       Date:  2009-01

Review 4.  Urological aspects of HIV and AIDS.

Authors:  Chris F Heyns; Shaun G Smit; André van der Merwe; Amir D Zarrabi
Journal:  Nat Rev Urol       Date:  2013-10-29       Impact factor: 14.432

5.  Factors associated with urinary tract infections among HIV-1 infected patients.

Authors:  Agata Skrzat-Klapaczyńska; Bartłomiej Matłosz; Agnieszka Bednarska; Marcin Paciorek; Ewa Firląg-Burkacka; Andrzej Horban; Justyna D Kowalska
Journal:  PLoS One       Date:  2018-01-11       Impact factor: 3.240

Review 6.  Kaposi sarcoma in unusual locations.

Authors:  Liron Pantanowitz; Bruce J Dezube
Journal:  BMC Cancer       Date:  2008-07-07       Impact factor: 4.430

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.